FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy

The described case of FIP1L1-PDGFRА-positive myeloproliferative disease is characterized by an atypical aggressive course to develop severe specific complications as injuries to the brain, heart, lung, and intestine. Pathogenetic therapy with imatinib could stabilize a patient’s state, but failed to...

Full description

Bibliographic Details
Main Authors: I S Nemchenko, A G Turkina, E Yu Chelysheva, G M Galstyan, A M Kovrigina, N K Khuazheva, V G Savchenko
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2015-12-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31887
_version_ 1818258968422645760
author I S Nemchenko
A G Turkina
E Yu Chelysheva
G M Galstyan
A M Kovrigina
N K Khuazheva
V G Savchenko
author_facet I S Nemchenko
A G Turkina
E Yu Chelysheva
G M Galstyan
A M Kovrigina
N K Khuazheva
V G Savchenko
author_sort I S Nemchenko
collection DOAJ
description The described case of FIP1L1-PDGFRА-positive myeloproliferative disease is characterized by an atypical aggressive course to develop severe specific complications as injuries to the brain, heart, lung, and intestine. Pathogenetic therapy with imatinib could stabilize a patient’s state, but failed to produce a complete hematological response. Switching from imatinib to dasatinib could produce sustained clinical, hematological, and molecular remissions.
first_indexed 2024-12-12T18:07:58Z
format Article
id doaj.art-0e14bdbcc0964fee84f3d820fdd9b587
institution Directory Open Access Journal
issn 0040-3660
2309-5342
language Russian
last_indexed 2024-12-12T18:07:58Z
publishDate 2015-12-01
publisher "Consilium Medicum" Publishing house
record_format Article
series Терапевтический архив
spelling doaj.art-0e14bdbcc0964fee84f3d820fdd9b5872022-12-22T00:16:27Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422015-12-018712899528903FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapyI S NemchenkoA G TurkinaE Yu ChelyshevaG M GalstyanA M KovriginaN K KhuazhevaV G SavchenkoThe described case of FIP1L1-PDGFRА-positive myeloproliferative disease is characterized by an atypical aggressive course to develop severe specific complications as injuries to the brain, heart, lung, and intestine. Pathogenetic therapy with imatinib could stabilize a patient’s state, but failed to produce a complete hematological response. Switching from imatinib to dasatinib could produce sustained clinical, hematological, and molecular remissions.https://ter-arkhiv.ru/0040-3660/article/view/31887hypereosinophilic syndromeclonal myeloproliferative disease with eosinophiliaimatinibdasatinib
spellingShingle I S Nemchenko
A G Turkina
E Yu Chelysheva
G M Galstyan
A M Kovrigina
N K Khuazheva
V G Savchenko
FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy
Терапевтический архив
hypereosinophilic syndrome
clonal myeloproliferative disease with eosinophilia
imatinib
dasatinib
title FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy
title_full FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy
title_fullStr FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy
title_full_unstemmed FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy
title_short FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy
title_sort fip1l1 pdgfrа positive myeloproliferative disease with eosinophilia a rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy
topic hypereosinophilic syndrome
clonal myeloproliferative disease with eosinophilia
imatinib
dasatinib
url https://ter-arkhiv.ru/0040-3660/article/view/31887
work_keys_str_mv AT isnemchenko fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy
AT agturkina fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy
AT eyuchelysheva fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy
AT gmgalstyan fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy
AT amkovrigina fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy
AT nkkhuazheva fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy
AT vgsavchenko fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy